Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||
| Net Income | -6,938 | -11,636 | -3,464 |
| Depreciation Amortization | 313 | 13 | 4 |
| Income taxes - deferred | -12,722 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,527 | 536 | -146 |
| Other Working Capital | 1,843 | 2,201 | 293 |
| Other Operating Activity | -174 | 1,070 | 172 |
| Operating Cash Flow | $-16,151 | $-7,816 | $-3,141 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -94 | -10 | -27 |
| Net Acquisitions | -30,994 | N/A | N/A |
| Purchase Of Investment | -5,169 | -6,627 | -6,382 |
| Sale Of Investment | 6,881 | 6,627 | N/A |
| Purchase Sale Intangibles | 0 | -1,000 | N/A |
| Other Investing Activity | 141 | -1,000 | -140 |
| Investing Cash Flow | $-29,235 | $-1,010 | $-6,549 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 14,914 | N/A | N/A |
| Common Stock Issued | 56,800 | 405 | N/A |
| Common Stock Repurchased | -6 | N/A | N/A |
| Other Financing Activity | 789 | 16,392 | 7,542 |
| Financing Cash Flow | $72,497 | $16,797 | $7,542 |
| Beginning Cash Position | 13,973 | 6,002 | 8,150 |
| End Cash Position | 41,084 | 13,973 | 6,002 |
| Net Cash Flow | $27,111 | $7,971 | $-2,148 |
| Free Cash Flow | |||
| Operating Cash Flow | -16,151 | -7,816 | -3,141 |
| Capital Expenditure | -94 | -10 | -27 |
| Free Cash Flow | -16,245 | -7,826 | -3,168 |